Jan 28, 2022 | 2022, Uncategorized
In 2020, antibodies driven by their widespread application in research, diagnosis, drug development and disease treatment, accounted for the largest share of the in-vitro diagnostic (IVD) market. The traditional method of hybridoma technology is popularly used to...
Jan 7, 2022 | Uncategorized
Dear Customer, Hereby, we would like to inform you that we have adapted our standard processes for the purification of antibodies via Protein G affinity chromatography. At InVivo, we are constantly striving to evaluate and further optimize existing processes in order...
Oct 8, 2021 | Uncategorized
We are delighted to be a part of the new reality that is no longer virtual. Our representatives will await and welcome your presence at MEDICA 2021 at Düsseldorf. Do not miss this opportunity to meet us at Booth C11, Hall 3 from November 15-18, 2021 and share your...
Aug 16, 2021 | Uncategorized
The AACC Annual Scientific Meeting & Clinical Lab Expo will be held from September 26-30, 2021 at Atlanta, Georgia. Don’t miss this chance to meet members of the global research community to discuss the future of lab and beyond! At booth number 3543, you...
Apr 28, 2021 | Uncategorized
Test systems that want to detect all SARS-CoV-2 variants need to stay flexible and highly adaptable. Transient gene expression in HEK cells is a highly suitable method to quickly produce sufficient amounts of proteins for research and development. In addition, stable...
Apr 8, 2021 | Uncategorized
De novo sequencing of mABs with QTOF MS CeMOS – Center for Mass Spectrometry and Optical Spectroscopy, recently demonstrated in collaboration with Bruker Daltonics and InVivo the complete de novo sequencing of a human monoclonal IgG using QTOF mass spectrometry....
